Zoledronate Prevents Morphometric Vertebral Fractures Over 10 Years

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 16, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Jan. 15, 2025 -- For early postmenopausal women, zoledronate administered at baseline and five years is effective for preventing morphometric vertebral fracture, according to a study published in the Jan. 16 issue of the New England Journal of Medicine.

Mark J. Bolland, M.B., Ch.B., Ph.D., from the University of Auckland in New Zealand, and colleagues conducted a 10-year prospective double-blind trial involving early postmenopausal women (age 50 to 60 years) with bone mineral density T scores lower than 0 and higher than −2.5 at the lumbar spine, femoral neck, or hip. Participants were randomly assigned to receive an infusion of zoledronate (5 mg) at baseline and at five years (zoledronate-zoledronate group), zoledronate (5 mg) at baseline and placebo at five years (zoledronate-placebo group), or placebo at both baseline and five years (placebo-placebo group).

Overall, 1,003 of the 1,054 women completed 10 years of follow-up. The researchers found that 6.3, 6.6, and 11.1 percent of women in the zoledronate-zoledronate, zoledronate-placebo, and placebo-placebo groups, respectively, had a new morphometric fracture (relative risks, 0.56 and 0.59 for zoledronate-zoledronate and zoledronate-placebo, respectively, versus placebo-placebo). The relative risks of fragility fracture, any fracture, and major osteoporotic fracture were 0.72, 0.70, and 0.60, respectively, and 0.79, 0.77, and 0.71, respectively, for zoledronate-zoledronate versus placebo-placebo and for zoledronate-placebo versus placebo-placebo.

"Intravenous zoledronate administered once every five years reduced the incidence of morphometric vertebral fractures during a 10-year period," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-17 00:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords